Format

Send to

Choose Destination
Biochem Biophys Res Commun. 2009 Sep 25;387(3):558-63. doi: 10.1016/j.bbrc.2009.07.058. Epub 2009 Jul 16.

Leucine-rich amelogenin peptide induces osteogenesis by activation of the Wnt pathway.

Author information

1
University of Southern California School of Dentistry, Center for Craniofacial Molecular Biology, 2250 Alcazar Street, Los Angeles, CA 90033, USA.

Abstract

We previously showed that one of the amelogenin splicing isoforms, Leucine-rich amelogenin peptide (LRAP), induced osteogenic differentiation of mouse embryonic stem cells; however, the signaling pathway(s) activated by LRAP remained unknown. Here, we demonstrated that the canonical Wnt/beta-catenin signaling is activated upon LRAP treatment, as evidenced by elevated beta-catenin level and increased Wnt reporter gene activity. Furthermore, a specific Wnt inhibitor sFRP-1 completely blocks the LRAP-mediated Wnt signaling. However, exogenous recombinant Wnt3a alone was less effective at osteogenic induction of mouse ES cells in comparison to LRAP. Using a quantitative real-time PCR array, we discovered that LRAP treatment up-regulated the expression of Wnt agonists and down-regulated the expression of Wnt antagonists. We conclude that LRAP activates the canonical Wnt signaling pathway to induce osteogenic differentiation of mouse ES cells through the concerted regulation of Wnt agonists and antagonists.

PMID:
19615979
PMCID:
PMC2758297
DOI:
10.1016/j.bbrc.2009.07.058
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center